Kronos Bio Inc (NASDAQ: KRON) open the trading on Thursday, with a bit cautious approach as it glided -3.15% to $0.92, before settling in for the price of $0.95 at the close. Taking a more long-term approach, KRON posted a 52-week range of $0.69-$1.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 0.00%. Meanwhile, its Annual Earning per share during the time was -72.78%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 33.33%. This publicly-traded company’s shares outstanding now amounts to $60.34 million, simultaneously with a float of $38.67 million. The organization now has a market capitalization sitting at $55.51 million. At the time of writing, stock’s 50-day Moving Average stood at $0.9388, while the 200-day Moving Average is $1.0348.
Kronos Bio Inc (KRON) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Kronos Bio Inc’s current insider ownership accounts for 35.92%, in contrast to 24.17% institutional ownership. According to the most recent insider trade that took place on Jun 27 ’24, this organization’s PRESIDENT & CEO bought 410,848 shares at the rate of 1.17, making the entire transaction reach 478,843 in total value, affecting insider ownership by 10,597,468. Preceding that transaction, on Jun 28 ’24, Company’s PRESIDENT & CEO bought 204,670 for 1.25, making the whole transaction’s value amount to 254,957. This particular insider is now the holder of 10,802,138 in total.
Kronos Bio Inc (KRON) Earnings and Revenue Records
Kronos Bio Inc’s EPS increase for this current 12-month fiscal period is 33.33% and is forecasted to reach -1.30 in the upcoming year.
Kronos Bio Inc (NASDAQ: KRON) Trading Performance Indicators
Let’s observe the current performance indicators for Kronos Bio Inc (KRON). It’s Quick Ratio in the last reported quarter now stands at 8.32. The Stock has managed to achieve an average true range (ATR) of 0.06. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.63.
In the same vein, KRON’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.44, a figure that is expected to reach -0.29 in the next quarter, and analysts are predicting that it will be -1.30 at the market close of one year from today.
Technical Analysis of Kronos Bio Inc (KRON)
[Kronos Bio Inc, KRON] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 27.51% While, its Average True Range was 0.0565.
Raw Stochastic average of Kronos Bio Inc (KRON) in the period of the previous 100 days is set at 27.91%, which indicates a major rise in contrast to 10.99% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 34.27% that was lower than 54.41% volatility it exhibited in the past 100-days period.
